Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NF-κB p65 mRNA is the messenger RNA transcript of the RELA gene, which encodes the p65 (RelA) subunit of the Nuclear Factor kappa-B (NF-κB) transcription factor complex (UniProt P19838). As a central component of the canonical NF-κB pathway, the p65 protein regulates the transcription of a vast array of genes involved in the innate and adaptive immune responses, cell survival, and inflammation (PubMed: 24336188). In various diseases, particularly chronic inflammatory conditions and cancers, the NF-κB pathway is pathologically overactivated, leading to the sustained production of pro-inflammatory cytokines and resistance to apoptosis (PubMed: 12486457). Targeting the p65 mRNA directly using RNA interference (RNAi) or antisense oligonucleotides (ASOs) allows for the specific knockdown of p65 protein synthesis, offering a therapeutic strategy to suppress aberrant NF-κB signaling (PubMed: 15123770). This approach is being explored to treat conditions such as rheumatoid arthritis, inflammatory bowel disease, and solid tumors. However, challenges remain regarding the efficient delivery of RNA-based therapeutics to target tissues and the potential for systemic toxicity or unintended immunosuppression due to the essential role of NF-κB in normal cellular homeostasis (PubMed: 16751388).
RNA interference and antisense-mediated degradation of mRNA leading to reduced protein translation
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear factor NF-kappa-B p65 subunit mRNA (RELA mRNA) (RELA mRNA).